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Much Remains to Be Learned about
How UVR Induces Mutations
Thomas M. Ru¨nger1
Data on the wavelength dependence of UV-induced formation of DNA damage
and skin cancer have been available for quite some time, but a detailed in vivo
action spectrum of mutation formation has not yet been reported so far. This
important information gap is filled by Ikehata et al. in this issue. Their findings
question several aspects of our current thinking about UV-induced mutagenesis
and carcinogenesis.
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Photocarcinogenesis is a cascade of
events in which malignant transforma-
tion in a single cell results from
UV-induced DNA damage, with subse-
quent mutation formation. Tens of
thousands of mutations all over the
genome of a single cell are usually
required to yield a sufficient number
of mutations in critical genes. An
impressive example of how many muta-
tions do occur in skin cancer was pro-
vided by Pleasance et al. (2010): they
sequenced the whole genome of a
melanoma and found more than 33,000
mutations. The fact that more than
23,000 of those were C to T single-base
transition mutations (¼UV-signature
mutations) provides impressive mole-
cular evidence that most of this large
mutation load is the consequence of
lifelong sun exposure. This confirms
the current concept that UV-induced
pyrimidine dimer–type DNA damage
(cis-syn cyclobutane pyrimidine dimers
and pyrimidine (6-4) pyrimidone photo-
products) with subsequent formation of C
to T transition mutations at sites of this
type of DNA damage are major drivers
of photocarcinogenesis. However, many
details about the mechanisms involved
in mutation formation after UV exposure
have remained elusive.
UVR consists of a spectrum of wave-
lengths that have different photo-physical,
photo-chemical, and photo-biological
effects. UVR action spectra describe
changes in these effects with varying
wavelengths. Such action spectra have
been available for the formation of DNA
damage (Freeman et al., 1989; Kielbassa
et al., 1997; Young et al., 1998) and for
the formation of skin cancer (de Gruijl
et al., 1993) in various in vitro and in vivo
models. Except for data of mutation
formation in cultured fibroblasts with
five different wavelengths of UVA (315–
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400 nm) and UVB (280–315nm; Enninga
et al., 1986), no action spectra for
mutation formation have been available
so far. In this issue, Ikehata et al. (2013)
describe a detailed action spectrum of
mutation formation in mice. They used
transgenic mice harboring the lacZ
mutagenesis target reporter gene and
studied the mutation formation separa-
tely in the dermis and in the epidermis,
following irradiation at 14 different
narrow-band wavelengths points, gene-
rated by a large high-intensity monochro-
mator or a 364-nm laser, ranging from
UVC to UVA1. The results close an
important gap in our knowledge about
UV-induced mutation formation and
carcinogenesis, as this is the first UVR
action spectrum of mutation formation
in vivo.
Is a severe sunburn more mutagenic and
carcinogenic than a mild sunburn?
In the epidermis, the authors observed
that mutation formation only increased
with increasing UVR doses until a
threshold dose was reached and then
leveled off. They termed this phenom-
enon as mutation induction suppression
(MIS), and the threshold dose as the
minimum mutation induction suppres-
sion dose (MMISD). It is apparently only
observed in vivo and not in cultured
cells. This is unlike the formation of
DNA damage by UVR that increases
with the dose of UVR and is not known
to level off. This new observation ques-
tions the concept that a higher dose of
UVR always results in more mutations.
There was a close correlation between
minimal erythema doses and the
MMISD. This indicates that a severe
sunburn may actually not produce more
mutations than a mild sunburn, and
therefore it may also not be more
carcinogenic than a mild sunburn.
Role of cellular or organism-based
damage responses on mutation formation
Many cellular defense mechanisms pre-
vent mutation formation at sites of DNA
damage, including DNA repair and cell
cycle arrest (to allow repair before replica-
tion of damaged DNA), so that a majority
of DNA lesions are actually repaired
before they cause mutations. The mechan-
ism by which mutation formation levels
off in vivo remains unclear, but Ikehata
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et al. (2013) propose that it may be the
result of a balance between mutation
formation and tissue destruction, with
apoptosis eliminating heavily damaged
cells and tissue renewal/repopulation
propagated by less damaged cells. How-
ever, at least in humans, typical erythemo-
genic doses induce apoptosis only in a
very small number of keratinocytes, as
evidenced by the formation of only a very
small number of sunburn cells. Therefore,
it is difficult to imagine how a few
sunburn cells can have such a profound
effect on mutation yield in the epi-
dermis. Preferential regeneration from
less damaged cells, e.g., stem cells, and
less regeneration from more damaged
cells, but not necessarily apoptotic cells,
may be at play.
Regardless of the mechanism, it
appears likely that the MIS is related to
damage responses, either at the cellular
or the tissue/organism level. For exam-
ple, using cultured human fibroblasts, we
have recently reported profound differ-
ences in cell cycle arrest following equi-
mutagenic doses of UVA and UVB, but no
significant differences in DNA repair or
apoptosis (Ru¨nger et al., 2012). As UVA
induced much less pyrimidine dimer–type
DNA damage than UVB with the doses
used, we put forward the hypothesis that
pyrimidine dimers generated by UVA
result in more mutations than pyrimidine
dimers generated by UVB, because the
antimutagenic response, in particular the
cell cycle arrest, is less effective with UVA
when compared with UVB. This is only
one example of how the risk of mutation
formation at a site of DNA damage can be
wavelength dependent, even if the muta-
tion-initiating lesions, namely pyrimidine
dimers, are the same. There are likely
several other determinants of mutation
formation following a given amount of
DNA damage, and some of those may
indeed be acting at the tissue or organism
level and not only at the cellular level.
One such example is the removal of
mutated cells through immune surveillance
and how this protective mechanism is
altered differently by different wavelengths.
Is phototherapy with narrow-band UVB
particularly mutagenic and carcinogenic?
For most wavelengths, Ikehata et al.
(2013) could induce mutation forma-
tion only 2-fold to 3-fold above the
background levels of spontaneous muta-
tion formation, a number that is surpri-
singly small. Only with wavelengths
ranging from 310 to 320 nm, which is
at the border between UVB and UVA,
could the mutation frequency be raised
B40-fold above background. Therefore,
it appears that this range of wavelengths
may contribute much more to mutation
formation, and with that could possibly
be particularly carcinogenic. Humans
are normally not exposed to narrow
bands of UVR. If the higher contribution
of the 310–320 nm wavelengths to
mutation formation is due to weaker
damage responses, exposure to a broad
range of wavelengths, as e.g., with
natural sunlight, may negate the hyper-
mutability with the 310–320 nm range
by induction of damage responses via
the other wavelengths. However, if the
310–320 nm range specifically sup-
presses damage responses, broad ranges
of UVR that include the 310–320 nm
range might be as mutagenic as the
narrow range alone.
There are many differences between
mouse and human skin that preclude
direct application of Ikehata et al’s find-
ings to humans. Nevertheless, the
potential of the 310–320 nm range to
generate especially high rates of muta-
tion with high doses raises questions
about the safety of phototherapy with
narrow-band UVB, which falls right
within this range. This is one notable
exception from the above mentioned
statement that humans are usually not
exposed to narrow bands of UVR. Even
if the results cannot be transferred dir-
ectly to the estimation of mutation risk in
humans, they nevertheless indicate that it
is important to continue to observe
patients who have undergone photo-
therapy with narrow-band UVB for
long-term carcinogenic effects. Further-
more, focusing photoprotective measures
on this range of wavelengths, e.g., with
sunscreens, appears prudent. Fortunately,
there is no technical difficulty in filtering
radiation in the 310–320 nm range with
today’s sunscreen technology.
Our understanding of mutation formation
following exposure of the skin to UVR
remains incomplete
Although Ikehata’s detailed muta-
tion formation action spectrum adds
considerably to our understanding of UV
mutagenesis, and with that to our under-
standing of UV carcinogenesis, there
remains much to be learned. Questions
that need answers are the effects of
different wavelengths on antimutagenic
responses and how those interact with
each other (see, e.g., Ru¨nger, 2007),
mutagenicity of narrow bands and broa-
der bands of UVR, how mutation forma-
tion is affected by cell-specific differences
(e.g., is UV mutagenesis different in
melanocytes, compared with keratino-
cytes? See Ru¨nger, 2010), by repeated
exposures at varying intervals, by different
fluence rates, and how UV-mutator
phenotypes, e.g., in p53-deficient cells,
affect all of these factors.
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Clinical Implications
 A severe sunburn may not be more mutagenic and carcinogenic than a
mild sunburn.
 High doses of UVR with wavelengths between 310 and 320nm may
contribute more to mutation formation and photocarcinogenesis than
high doses of other wavelengths.
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Systemic Protein Therapy for Recessive
Dystrophic Epidermolysis Bullosa: How
Far Are We from Clinical Translation?
Alain Hovnanian1,2,3
In this issue, Woodley et al. report restoration of anchoring fibril formation and
dermal–epidermal adherence in a murine model of recessive dystrophic epider-
molysis bullosa (RDEB) by intravenous injection of recombinant human type VII
collagen. This work follows a previous report by the same group of the surprising
capability of intradermally injected type VII collagen protein to reverse RDEB, and
it opens new therapeutic avenues.
Journal of Investigative Dermatology (2013) 133, 1719–1721. doi:10.1038/jid.2013.137
Dystrophic epidermolysis bullosa (DEB)
is a group of heritable mechano-bullous
skin diseases characterized by skin fra-
gility, separation of the epidermis from
the dermis, milia formation, and scar-
ring (Fine et al., 2008). DEB is
transmitted in either a recessive (RDEB)
or a dominant (DDEB) manner. All
forms of DEB are caused by mutations
in COL7A1-encoding type VII collagen
that forms anchoring fibrils (AFs) at the
basement membrane zone (BMZ).
Patients with DEB show absent or
reduced and abnormal AF. The most
severe RDEB forms present with
extensive skin erosions, fusion of
fingers and toes, joint contractures, and
esophageal strictures, which cause
severe dysphagia and malnutrition.
Skin infections, anemia, and aggressive
squamous cell carcinomas are frequent
complications. DEB remains to be a
group of diseases that have no satis-
factory treatments.
Gene and cell therapy approaches
Initial gene therapy studies used in vivo
intradermal injection of gene-corrected
DEB fibroblasts or lentiviral vectors
expressing C7. After the first successful
transplantation of gene-corrected ker-
atinocyte autografts in a patient with
junctional EB (Mavilio et al., 2006),
several laboratories have developed
ex vivo transplantation of epithelia or
skin equivalents genetically corrected
with classical or self-inactivating
retroviral COL7A1 vectors (Siprashvili
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et al., 2010; Titeux et al., 2010), and
two clinical trials have been initiated.
In parallel, intradermal injection of
allogenic fibroblasts has shown
the effectiveness of cell therapy
(Wong et al., 2008). However, these
approaches require multiple injections
and/or grafting. To address the
extensive nature of the skin and
mucosal lesions in RDEB, alternative
strategies using systemic delivery
of therapeutic agents have been
developed. Injection of genetically
engineered human fibroblasts
overexpressing C7 into the systemic
circulation of a murine model was
reported to deliver C7 at wound sites
where they were incorporated into the
skin’s BMZ, forming AF (Woodley
et al., 2007). Recently, bone marrow
and cord blood transplantation of
HLA-matched donors led to clinical
improvement in patients with severe
disease (Wagner et al., 2010).
Protein replacement: from local to
systemic delivery
In the case of RDEB, protein replace-
ment consists in delivering recombinant
human type VII collagen (C7) protein
locally or systemically. This approach
demonstrated unexpected efficacy when
intradermally injected human C7 was
reported to incorporate stably into the
BMZ of wild-type mice, as well as into
regenerated human RDEB equivalent
skin transplanted onto immune-compro-
mised mice (Woodley et al., 2004).
Injection of C7 corrected the
subepidermal blistering and restored
type VII collagen expression in the
BMZ for at least 2 months after a
single injection. Immunogold labeling
showed that the injected C7 was
organized into AF structures. These
results were supported further by
intradermal injection of human C7 in a
murine model of RDEB (Remington
et al., 2009). The injected human C7
incorporated stably into the BMZ of
RDEB mice, formed AF, and corrected
the disease phenotype, leading to
markedly prolonged survival. Remar-
kably, the treated RDEB mice deve-
loped circulating anti-human C7 anti-
bodies that did not bind to the mouse’s
BMZ, nor did it prevent AF formation.
Finally, treatment of the mice with an
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